• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A survey of current United Kingdom practice for antenatal screening for inherited disorders of globin chain synthesis. UK Forum for Haemoglobin Disorders.英国目前关于珠蛋白链合成遗传性疾病产前筛查实践的调查。英国血红蛋白疾病论坛。
J Clin Pathol. 1998 May;51(5):382-9. doi: 10.1136/jcp.51.5.382.
2
Screening and prenatal diagnosis of the haemoglobinopathies.血红蛋白病的筛查与产前诊断
Baillieres Clin Haematol. 1993 Mar;6(1):263-86. doi: 10.1016/s0950-3536(05)80072-1.
3
An analysis of relative costs and potential benefits of different policies for antenatal screening for beta thalassaemia trait and variant haemoglobins.β地中海贫血特征和异常血红蛋白产前筛查不同政策的相对成本及潜在效益分析
J Clin Pathol. 1999 Sep;52(9):697-700. doi: 10.1136/jcp.52.9.697.
4
The laboratory diagnosis of haemoglobinopathies.血红蛋白病的实验室诊断。
Br J Haematol. 1998 Jun;101(4):783-92. doi: 10.1046/j.1365-2141.1998.00809.x.
5
Organisation and cost-effectiveness of antenatal haemoglobinopathy screening and follow up in a community-based programme.社区项目中产前血红蛋白病筛查及随访的组织与成本效益
BJOG. 2000 Apr;107(4):486-91. doi: 10.1111/j.1471-0528.2000.tb13267.x.
6
[A study on gene mutation spectrums of α- and β-thalassemias in populations of Yunnan Province and the prenatal gene diagnosis].云南省人群α和β地中海贫血基因突变谱及产前基因诊断研究
Zhonghua Fu Chan Ke Za Zhi. 2012 Feb;47(2):85-9.
7
Thalassaemia screening in pregnancy.孕期地中海贫血筛查
Curr Opin Obstet Gynecol. 2005 Apr;17(2):129-34. doi: 10.1097/01.gco.0000162180.22984.a3.
8
Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology Guideline.显著血红蛋白病:筛查和诊断指南:英国血液学学会指南:英国血液学学会指南。
Br J Haematol. 2023 Jun;201(6):1047-1065. doi: 10.1111/bjh.18794. Epub 2023 Apr 19.
9
Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years.英国血红蛋白病产前诊断审计:头20年
BMJ. 1997 Sep 27;315(7111):779-84. doi: 10.1136/bmj.315.7111.779.
10
Antenatal diagnosis of haemoglobinopathies by Biorex chromatography of haemoglobin.通过血红蛋白的生物 Rex 色谱法进行血红蛋白病的产前诊断。
Br J Haematol. 1982 Jan;50(1):7-15. doi: 10.1111/j.1365-2141.1982.tb01885.x.

引用本文的文献

1
Antenatal haemoglobinopathy screening - Experiences of a large Australian Centre.产前血红蛋白病筛查——澳大利亚一个大型中心的经验
Obstet Med. 2021 Jun;14(2):89-94. doi: 10.1177/1753495X20944708. Epub 2020 Aug 19.
2
Antenatal haemoglobinopathy screening: Patterns within a large obstetric service. Working towards a standard of care.产前血红蛋白病筛查:大型产科服务中的模式。朝着护理标准努力。
Obstet Med. 2015 Dec;8(4):184-9. doi: 10.1177/1753495X15598698. Epub 2015 Sep 1.
3
High performance liquid chromatography (HPLC) as a screening tool for classical Beta-thalassaemia trait in malaysia.高效液相色谱法(HPLC)作为马来西亚典型β地中海贫血特征的筛查工具。
Malays J Med Sci. 2001 Jul;8(2):40-6.
4
Carrier screening for beta-thalassaemia: a review of international practice.β-地中海贫血症携带者筛查:国际实践综述。
Eur J Hum Genet. 2010 Oct;18(10):1077-83. doi: 10.1038/ejhg.2010.90. Epub 2010 Jun 23.

本文引用的文献

1
Screening criteria for beta thalassaemia trait in pregnant women.孕妇β地中海贫血特征的筛查标准。
J Clin Pathol. 1995 Nov;48(11):1054-6. doi: 10.1136/jcp.48.11.1054.
2
Choice of anticoagulants for packed cell volume and mean cell volume determination.用于红细胞压积和平均红细胞体积测定的抗凝剂选择。
Clin Lab Haematol. 1984;6(3):305-6. doi: 10.1111/j.1365-2257.1984.tb00557.x.

英国目前关于珠蛋白链合成遗传性疾病产前筛查实践的调查。英国血红蛋白疾病论坛。

A survey of current United Kingdom practice for antenatal screening for inherited disorders of globin chain synthesis. UK Forum for Haemoglobin Disorders.

作者信息

Bain B J, Chapman C

机构信息

Department of Haematology, Leicester Royal Infirmary Children's Hospital, UK.

出版信息

J Clin Pathol. 1998 May;51(5):382-9. doi: 10.1136/jcp.51.5.382.

DOI:10.1136/jcp.51.5.382
PMID:9708206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC500700/
Abstract

AIMS

To document current United Kingdom practice for antenatal screening for inherited disorders of globin chain synthesis and to compare such practice with guidelines published by the British Committee for Standards in Haematology and the Standing Committee on Sickle Cell, Thalassaemia and other Haemoglobinopathies (SMAC).

METHODS

The members of the UK Forum on Haemoglobin Disorders were surveyed about their current practice for antenatal haemoglobinopathy screening. The UK Forum is a national group of haematologists, paediatricians, laboratory scientists, and counsellors working in the field of diagnosis and management of disorders of haemoglobin synthesis; such disorders including the alpha and beta thalassaemias, sickle cell disease, and other haemoglobinopathies.

RESULTS

Completed questionnaires from 38 hospitals (or cooperating groups of hospitals) were analysed. The great majority of hospitals were applying appropriate laboratory methods, but problems were commonly encountered in ensuring that appropriate testing of antenatal patients and, when necessary, of their partners, was carried out early in pregnancy. When screening was selective there was quite often a failure to identify all women in whom testing was indicated, and cut off points used as an indication for further testing were sometimes inappropriate.

CONCLUSIONS

Many practical problems are still encountered in following guidelines for the antenatal diagnosis of haemoglobinopathies. A need for improved administrative procedures and increased funding was identified. In addition there is a need for agreed guidelines giving more specific advice on technical aspects of laboratory practice.

摘要

目的

记录英国目前对珠蛋白链合成遗传性疾病进行产前筛查的做法,并将这种做法与英国血液学标准委员会以及镰状细胞、地中海贫血和其他血红蛋白病常务委员会(SMAC)发布的指南进行比较。

方法

对英国血红蛋白病论坛的成员进行了调查,了解他们目前进行产前血红蛋白病筛查的做法。英国论坛是一个由从事血红蛋白合成疾病诊断和管理领域工作的血液学家、儿科医生、实验室科学家和咨询师组成的全国性团体;这些疾病包括α和β地中海贫血、镰状细胞病和其他血红蛋白病。

结果

分析了来自38家医院(或合作医院组)的完整问卷。绝大多数医院都采用了适当的实验室方法,但在确保对产前患者及其必要时对其伴侣进行适当检测在妊娠早期进行方面,普遍遇到问题。当筛查具有选择性时,常常未能识别出所有需要检测的女性,并且用作进一步检测指征的临界值有时并不合适。

结论

在遵循血红蛋白病产前诊断指南方面,仍然遇到许多实际问题。确定需要改进行政程序并增加资金。此外,还需要商定的指南,就实验室操作的技术方面提供更具体的建议。